Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 184,527	$ 12,913
Advances to Suppliers	23,781	10,830
Inventories	269,307	245,776
Total current assets	477,615	269,519
Fixed assets, net	28,333	31,337
Investment in equity method investee	100	100
TOTAL ASSETS	506,048	300,956
Current liabilities
Accounts payable and accrued liabilities	250,192	206,873
Due to related parties	50,000	45,000
Convertible notes payable, net of discount	2,365,000	1,865,000
Derivative liability	1,119,175	2,286,014
Settlement liability
Current liabilities of discontinued operations
Total current liabilities	3,784,367	4,402,887
Total liabilities	3,784,367	4,402,887
Stockholders’ deficit
Common stock; $0.0001 par value; 100,000,000 shares authorized; 47,796,859 and 45,046,637 shares issued and outstanding as of March 31, 2022 December 31, 2021 , respectively.	4,779	4,504
Stock subscription receivable	(261,059)
Additional paid-in capital	22,461,772	21,867,416
Accumulated deficit	(25,484,011)	(25,974,051)
Total Stockholders’ deficit	(3,278,319)	(4,101,931)
TOTAL LIABILITIES AND STOCKHOLDER’S DEFICIT	506,048	300,956
Series B Preferred Stock [Member]
Stockholders’ deficit
Preferred stock, value
Series C Preferred Stock [Member]
Stockholders’ deficit
Preferred stock, value	$ 200	$ 200